Dr David Weinkove

Dr. David Weinkove co-founded Magnitude Biosciences, a specialist C. elegans CRO, to help pharma, biotech and industrial R&D tap into the power of C. elegans to accelerate their research. David is also an Associate Professor at the Department of Biosciences, Durham University, and has published 20 peer reviewed papers and has over 3000 citations of his work.

In addition to being a thought leader in C. elegans research for over 20 years, David has broad knowledge and extensive practical experience in many fields in biological sciences. David has a particular interest in the field of geroscience, with experience identifying compounds that are effective in slowing ageing and showing the route to target identification to allow them to progress drugs to the next stage of the preclinical pathway and receive support from investors. Additionally, David has experience quantifying acute and reproductive toxicity of key components used by large consumer goods manufacturers as well as assessing the health benefits of probiotics or microbes.